Clinical trial
RANDOMIZED PHASE II TRIAL OF AUTOLOGOUS TUMOR CELL VACCINE
NCT00002505 is registered in ClinicalTrials.gov with Hoag Memorial Hospital Presbyterian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RANDOMIZED PHASE II TRIAL OF AUTOLOGOUS TUMOR CELL VACCINE
- Lead sponsor
- Hoag Memorial Hospital Presbyterian
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 1992
- Completion date
- May 31, 2006
- Enrollment
- Not reported
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
unspecified adult solid tumor, protocol specific